6505--Baclofen Tablets (VA-25-00026620)

The Department of Veterans Affairs National Acquisition Center is seeking a contractor to supply Baclofen tablets for distribution through VA and DoD Pharmaceutical Prime Vendor (PPV) Programs. The solicitation requires one contractor to provide five variations of Baclofen tablets in different strengths and bottle counts, including 10mg, 20mg, and 5mg tablets in 100-count and 500/1000-count bottles. Key contract requirements include providing FDA-approved products, complying with the Drug Supply Chain Security Act, including bar coding, and specific NDC numbers unique to the offering company. The RFP includes a 0.5% Cost Recovery Fee to be integrated into pricing, and contractors must establish business agreements with PPV distributors. The proposal responses are due February 5, 2025, at 2:30 PM CST, with an implementation period of 60 days maximum after award, contingent on the award date.

The solicitation is an unrestricted competition with a HUBZone price evaluation preference, meaning no specific set-aside designations are in place. The contract will support multiple federal healthcare facilities, including VA, DoD, Indian Health Service, Bureau of Prisons, Federal Health Care Center, and Option 2 State Veterans Homes. Estimated annual quantities vary by tablet strength, ranging from 3,079 to 78,356 bottles. The contract structure includes a base year with four additional one-year option periods, providing potential long-term stability for the selected contractor. While specific award values are not explicitly stated, the pharmaceutical nature of the contract and the broad range of supported facilities suggest a significant potential contract value. Contractors must be prepared to distribute products through the established Pharmaceutical Prime Vendor Programs, indicating a complex supply chain management requirement.